Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 300

1.

Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.

Kloppenborg RP, Nederkoorn PJ, Grool AM, Vincken KL, Mali WP, Vermeulen M, van der Graaf Y, Geerlings MI; SMART Study Group..

Neurology. 2012 Nov 13;79(20):2029-36. doi: 10.1212/WNL.0b013e3182749f02. Epub 2012 Oct 31.

PMID:
23115210
2.

White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study.

Appelman AP, Vincken KL, van der Graaf Y, Vlek AL, Witkamp TD, Mali WP, Geerlings MI; SMART Study Group..

Cerebrovasc Dis. 2010;29(1):28-35. doi: 10.1159/000255971. Epub 2009 Nov 5.

PMID:
19893309
3.

Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy--the SMART-MR study.

Jochemsen HM, Geerlings MI, Grool AM, Vincken KL, Mali WP, van der Graaf Y, Muller M.

J Alzheimers Dis. 2012;29(1):39-49. doi: 10.3233/JAD-2012-111772.

PMID:
22214784
4.

Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study.

Geerlings MI, Appelman AP, Vincken KL, Algra A, Witkamp TD, Mali WP, van der Graaf Y; SMART Study Group..

Atherosclerosis. 2010 May;210(1):130-6. doi: 10.1016/j.atherosclerosis.2009.10.039. Epub 2009 Nov 10.

PMID:
19945704
5.

Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years follow-up.

Grool AM, Gerritsen L, Zuithoff NP, Mali WP, van der Graaf Y, Geerlings MI.

Biol Psychiatry. 2013 Jan 15;73(2):169-76. doi: 10.1016/j.biopsych.2012.08.024. Epub 2012 Oct 16.

PMID:
23079234
6.

Mood problems increase the risk of mortality in patients with lacunar infarcts: the SMART-MR study.

Grool AM, van der Graaf Y, Mali WP, Witkamp TD, Vincken KL, Geerlings MI; SMART Study Group..

Psychosom Med. 2012 Apr;74(3):234-40. doi: 10.1097/PSY.0b013e31824f5ab0. Epub 2012 Mar 20.

PMID:
22434917
7.

Antidepressant use is related to larger white matter lesion volume in patients with symptomatic atherosclerotic disease: the SMART-MR study.

Grool AM, van der Graaf Y, Vincken KL, Witkamp TD, Mali WP, Geerlings MI.

J Neurol. 2013 Jan;260(1):197-206. doi: 10.1007/s00415-012-6616-1. Epub 2012 Aug 5.

PMID:
22865237
8.

Location of cerebrovascular and degenerative changes, depressive symptoms and cognitive functioning in later life: the SMART-Medea study.

Grool AM, van der Graaf Y, Mali WP, Geerlings MI; SMART Study Group..

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1093-100. doi: 10.1136/jnnp.2010.232413. Epub 2011 Apr 1.

PMID:
21459931
9.

Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study.

Ikram MK, De Jong FJ, Van Dijk EJ, Prins ND, Hofman A, Breteler MM, De Jong PT.

Brain. 2006 Jan;129(Pt 1):182-8. Epub 2005 Nov 29.

PMID:
16317022
10.

Arterial stiffness and progression of structural brain changes: The SMART-MR study.

Jochemsen HM, Muller M, Bots ML, Scheltens P, Vincken KL, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group..

Neurology. 2015 Feb 3;84(5):448-55. doi: 10.1212/WNL.0000000000001201. Epub 2014 Dec 31.

PMID:
25552578
11.

Total cerebral blood flow, white matter lesions and brain atrophy: the SMART-MR study.

Appelman AP, van der Graaf Y, Vincken KL, Tiehuis AM, Witkamp TD, Mali WP, Geerlings MI; SMART Study Group..

J Cereb Blood Flow Metab. 2008 Mar;28(3):633-9. Epub 2007 Oct 3.

PMID:
17912270
12.

Association of white matter lesions and lacunar infarcts with executive functioning: the SMART-MR study.

Geerlings MI, Appelman AP, Vincken KL, Mali WP, van der Graaf Y; SMART Study Group..

Am J Epidemiol. 2009 Nov 1;170(9):1147-55. doi: 10.1093/aje/kwp256. Epub 2009 Sep 25.

PMID:
19783584
13.

Location and progression of cerebral small-vessel disease and atrophy, and depressive symptom profiles: the Second Manifestations of ARTerial disease (SMART)-Medea study.

Grool AM, van der Graaf Y, Mali WP, Witkamp TD, Vincken KL, Geerlings MI; SMART Study Group..

Psychol Med. 2012 Feb;42(2):359-70. doi: 10.1017/S0033291711001383. Epub 2011 Aug 11.

PMID:
21835088
14.

Vascular brain lesions, brain atrophy, and cognitive decline. The Second Manifestations of ARTerial disease--Magnetic Resonance (SMART-MR) study.

Kooistra M, Geerlings MI, van der Graaf Y, Mali WP, Vincken KL, Kappelle LJ, Muller M, Biessels GJ; SMART-MR Study Group..

Neurobiol Aging. 2014 Jan;35(1):35-41. doi: 10.1016/j.neurobiolaging.2013.07.004. Epub 2013 Aug 7.

15.

Carotid atherosclerosis and progression of brain atrophy: the SMART-MR study.

Muller M, van der Graaf Y, Algra A, Hendrikse J, Mali WP, Geerlings MI; SMART Study Group..

Ann Neurol. 2011 Aug;70(2):237-44. doi: 10.1002/ana.22392. Epub 2011 Jun 14.

PMID:
21674583
16.

How much do focal infarcts distort white matter lesions and global cerebral atrophy measures?.

Wang X, Valdés Hernández MC, Doubal F, Chappell FM, Wardlaw JM.

Cerebrovasc Dis. 2012;34(5-6):336-42. doi: 10.1159/000343226. Epub 2012 Nov 14.

17.

Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study.

Kloppenborg RP, Nederkoorn PJ, van der Graaf Y, Geerlings MI.

Atherosclerosis. 2011 Jun;216(2):461-6. doi: 10.1016/j.atherosclerosis.2011.02.027. Epub 2011 Feb 24.

18.

Longitudinal changes in brain volumes and cerebrovascular lesions on MRI in patients with manifest arterial disease: the SMART-MR study.

van der Veen PH, Muller M, Vincken KL, Witkamp TD, Mali WP, van der Graaf Y, Geerlings MI; SMART-MR Study Group..

J Neurol Sci. 2014 Feb 15;337(1-2):112-8. doi: 10.1016/j.jns.2013.11.029. Epub 2013 Nov 27.

19.

Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study.

Conijn MM, Kloppenborg RP, Algra A, Mali WP, Kappelle LJ, Vincken KL, van der Graaf Y, Geerlings MI; SMART Study Group..

Stroke. 2011 Nov;42(11):3105-9. doi: 10.1161/STROKEAHA.110.594853. Epub 2011 Aug 25.

20.

Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis.

Yamauchi H, Fukuda H, Oyanagi C.

J Neurol Neurosurg Psychiatry. 2002 May;72(5):576-82.

Supplemental Content

Support Center